STOCK TITAN

Planned sale of 8,588 PTGX (NASDAQ: PTGX) shares disclosed in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of the issuer’s common stock has filed a notice of proposed sale under Rule 144 for 8,588 shares. The planned sale is to be executed through Morgan Stanley Smith Barney on or about 01/20/2026, with an indicated aggregate market value of 708,338.24. The issuer reports 62,515,666 shares outstanding, which is a baseline figure for the company’s equity.

The shares to be sold were acquired as restricted stock vesting under a registered plan from the issuer on 01/20/2026, as compensation for services rendered. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for PTGX disclose?

The Form 144 shows that a holder of common stock of the issuer intends to sell 8,588 shares under Rule 144 through Morgan Stanley Smith Barney, with an aggregate market value of 708,338.24 and a planned sale date of 01/20/2026.

How many PTGX shares are planned to be sold and on which exchange?

The notice covers the proposed sale of 8,588 common shares, to be sold on NASDAQ as indicated in the filing.

How were the PTGX shares being sold under Form 144 acquired?

The securities were acquired as restricted stock vesting under a registered plan from the issuer on 01/20/2026, in exchange for services rendered.

What is the aggregate market value of the PTGX shares in this Form 144?

The Form 144 lists an aggregate market value of 708,338.24 for the 8,588 common shares proposed to be sold.

How many PTGX shares are outstanding according to this filing?

The Form 144 indicates that there are 62,515,666 common shares outstanding for the issuer at the time of the notice.

What representation does the selling person make in the PTGX Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the proposed PTGX Rule 144 sale?

The filing lists Morgan Stanley Smith Barney Operations Department, located at 2000 Westchester Ave, Purchase, NY 10577-2530, as the broker for the proposed sale.

Protagonist Ther

NASDAQ:PTGX

View PTGX Stock Overview

PTGX Rankings

PTGX Latest News

PTGX Latest SEC Filings

PTGX Stock Data

6.09B
61.29M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEWARK